Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-138734

Published: 2020

Journal Articles

To Explore the Effect of Haploidentical Transplantation in the Treatment of Pediatric T-ALL with Sil-TAL1 Fusion Gene Positive and Analysis of Prognostic Factors

Huili Zhu, MD, Peihua Lu, MD, Deyan Liu, Yanli Zhao, Jiarui Zhou, Jianping Zhang, Xingyu Cao, Yue Lu, Zhijie Wei

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-139583

Published: 2020

Journal Articles

Clinical Effect of Haploid-SCT and SCT from an Unrelated Donor for Severe Aplastic Anemia (SAA): A Retrospective Single-Center Study

Zhijie Wei, Fei Pan, Yue Guanlan, Gao Kang, Rong Yang, Huili Zhu, MD, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 23.

https://doi.org/10.1182/blood-2020-142273

Published: 2020

Journal Articles

Screening Donor Samples Using Multicolor Flow Cytometry Prior to Allogeneic Hematopoietic Stem Cell Transplantation Can Improve Disease Monitoring Post-Transplantation

Hui Wang, MD, Aixian Wang, Meiwei Gong, Junyi Zhen, Xueying Wu, Man Chen, Qing Du, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-136277

Published: 2020

Journal Articles

A Monocentric Clinical Observation of Haploidientical Transplantation in 27 Patients with Acute Megakaryocytic Leukemia

Zhijie Wei, Fei Pan, Rong Yang, Shuquan Ji, MD, Yue Guanlan, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-137374

Published: 2020

Journal Articles

Factors Predicting Long-Term Survival Following CD19 CAR T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Xian Zhang, MD, Junfang Yang, Wenqian Li, Gailing Zhang, MD, Yunchao Su, Yanze Shi, Dan Song, Min Zhang, Jiujiang He, Li Xu, Jingjing Li, Xinan Lu, Jianqiang Li, PhD, Xiangqun Li, Zhongwei Xu, Ziyu Li, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-136897

Published: 2020

Journal Articles

A Feasibility and Safety Study of a Novel CD19-Directed Synthetic T-Cell Receptor and Antigen Receptor (STAR) T-Cell Therapy for Refractory and Relapsed (R/R) B Cell Acute Lymphoblastic Leukemia (B-ALL)

Xian Zhang, MD, Jiasheng Wang, Yue Liu, Junfang Yang, Jingjing Li, Gailing Zhang, MD, Yanze Shi, Jiujiang He, Dan Song, Wenqian Li, Shulian Xia, Min Zhang, Zhixiao Zhou, Lemei Jia, Hongli Zheng, Xin Lin, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-136833

Published: 2020

Journal Articles

Successful 24-Hours Manufacture of Anti-CD19/CD22 Dual Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Junfang Yang, Pengfei Jiang, Xian Zhang, MD, Jingjing Li, Yan Wu, Li Xu, Yunchao Su, Xiaona Hu, Xiaoyan Zhao, Qi Dong, Songbai Cai, Zhenguang Wang, Yuezhang Chen, Xun Ye, Jiaping He, Nanjing Lin, Wei Cao, Martina Sersch, MD PhD, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-136866

Published: 2020

Journal Articles

Feasibility, and Efficacy of Donor-Derived cd19-Targeted Car t-Cell Therapy in Refractory/Relapsed(r/r)b-Cell Acute Lymphoblastic Leukemia (b-all) Patients

Xian Zhang, MD, Junfang Yang, Wenqian Li, Gailing Zhang, MD, Yunchao Su, Yanze Shi, Dan Song, Min Zhang, Jiujiang He, Li Xu, Liyuan Qiu, Xin-An Lu, Fei Wu, Jianqiang Li, PhD, Dandan Chen, Xiangqun Li, Ziyu Li, Jingjing Li, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 4–6.

https://doi.org/10.1182/blood-2020-137299

Published: 2020

Journal Articles

Significant Long-Term Benefits of CAR T-Cell Therapy Followed By a Second Allo-HSCT for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Who Relapsed after an Initial Transplant

Jianping Zhang, Junfang Yang, Xian Zhang, MD, Jingjing Li, Xingyu Cao, Yanli Zhao, Zhijie Wei, Deyan Liu, Min Xiong, Yue Lu, Jiarui Zhou, Ruijuan Sun, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-136014

Published: 2020

Journal Articles

One Tube 24 Color Full Spectral Flow Cytometry and Multi-Dimensional Software to Study the Maturation Pattern and Antigen Expression of the Myeloid

Man Chen, Hui Wang, MD, Minjing Fu, Aixian Wang, Meiwei Gong, Junyi Zhen, Xueying Wu, Kun Zhao, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-140600

Published: 2020

Journal Articles

Peripheral Blood Monoclonal B-Cell and/or Plasma Cell Detection By Flow Cytometry in Screening and Monitoring EBV-Positive Post-Transplant Lymphoproliferative Disorders

Xueying Wu, Hui Wang, MD, Aixian Wang, Xingyu Cao, Meiwei Gong, Junyi Zhen, Man Chen, Qing Du, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 47.

https://doi.org/10.1182/blood-2020-135942

Published: 2020

Journal Articles

Detecting 24 Kinds of Cytokines Via Flow Cytometry Aimplex Kit Is an Effective Way to Monitor CRS after CAR-T Cells Infusion

Dongchu Wang, Xiang Li, Liyuan Qiu, Shizhe Fu, Lingyun Cui, Hui Wang, MD, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 50–51.

https://doi.org/10.1182/blood-2020-138404

Published: 2020

Journal Articles

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Biping Deng, MD, Alex Hongsheng Chang, Professor, Junfang Yang, MD, Jing Pan, MD, Xian Zhang, PhD, Yuehui Lin, MD, Yanan Wu, MD, Zhenling Deng, PhD, Peihua Lu, MD, Tong Wu, MD, Zhaoli Liu, Bachelor, Yu'e Zhang, Bachelor, Chunrong Tong, MD

Blood (2016) 128 (22): 649.

https://doi.org/10.1182/blood.V128.22.649.649

Published: 2016

NARROW

An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma

To Explore the Effect of Haploidentical Transplantation in the Treatment of Pediatric T-ALL with Sil-TAL1 Fusion Gene Positive and Analysis of Prognostic Factors

Clinical Effect of Haploid-SCT and SCT from an Unrelated Donor for Severe Aplastic Anemia (SAA): A Retrospective Single-Center Study

Screening Donor Samples Using Multicolor Flow Cytometry Prior to Allogeneic Hematopoietic Stem Cell Transplantation Can Improve Disease Monitoring Post-Transplantation

A Monocentric Clinical Observation of Haploidientical Transplantation in 27 Patients with Acute Megakaryocytic Leukemia

Factors Predicting Long-Term Survival Following CD19 CAR T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

A Feasibility and Safety Study of a Novel CD19-Directed Synthetic T-Cell Receptor and Antigen Receptor (STAR) T-Cell Therapy for Refractory and Relapsed (R/R) B Cell Acute Lymphoblastic Leukemia (B-ALL)

Successful 24-Hours Manufacture of Anti-CD19/CD22 Dual Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Feasibility, and Efficacy of Donor-Derived cd19-Targeted Car t-Cell Therapy in Refractory/Relapsed(r/r)b-Cell Acute Lymphoblastic Leukemia (b-all) Patients

Significant Long-Term Benefits of CAR T-Cell Therapy Followed By a Second Allo-HSCT for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Who Relapsed after an Initial Transplant

One Tube 24 Color Full Spectral Flow Cytometry and Multi-Dimensional Software to Study the Maturation Pattern and Antigen Expression of the Myeloid

Peripheral Blood Monoclonal B-Cell and/or Plasma Cell Detection By Flow Cytometry in Screening and Monitoring EBV-Positive Post-Transplant Lymphoproliferative Disorders

Detecting 24 Kinds of Cytokines Via Flow Cytometry Aimplex Kit Is an Effective Way to Monitor CRS after CAR-T Cells Infusion

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only